Glenmark receives ANDA approval for Olopatadine Hydrochloride ophthalmic solution USP, 0.2%
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Subscribe To Our Newsletter & Stay Updated